ng-nitroarginine methyl ester has been researched along with Coronary Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dendorfer, A; Dominiak, P; Heep, A; Klein, HH; Richardt, G; Schutt, M; Tempel, K; Weidtmann, B; Wolfrum, S | 1 |
| Barsacchi, R; Coceani, F; Kusmic, C; L'Abbate, A; Lazzerini, G; Sambuceti, G | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Coronary Stenosis
| Article | Year |
|---|---|
Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
Topics: Androstadienes; Animals; Cholesterol; Coronary Stenosis; Drug Administration Schedule; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Simvastatin; Time Factors; Wortmannin | 2004 |
Paradoxical coronary microcirculatory constriction during ischemia: a synergic function for nitric oxide and endothelin.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Coronary Stenosis; Coronary Vessels; Endothelins; Enzyme Inhibitors; Hemodynamics; Hypotension; Mice; Mice, Inbred C57BL; Microcirculation; Models, Cardiovascular; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oligopeptides; Piperidines; Reactive Oxygen Species; Vasoconstriction; Vasodilation; Vasomotor System | 2006 |